Kuros starts Phase II clinical trial in bone regeneration
Kuros reaches key milestone in its collaboration with Baxter
06-Feb-2007 -
Kuros, a biotechnology company that develops novel biologics and biomaterials for localised therapy, announced that it has started a Phase II clinical trial in tibial plateau fractures as part of its collaboration with Baxter in hard and soft tissue repair. The Phase II clinical trial will be ...
Baxter
biologics
biomaterials
+4